Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

822
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
822
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

415
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

469
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

630
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
630
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

756
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
756

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Has the bacteriology of periprosthetic joint infection after total knee arthroplasty changed over time? A retrospective cohort study of 2171 patients.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same author

[Role of lymphatic network in cardiac repair post myocardial infarction].

Zhonghua xin xue guan bing za zhi·2026
Same author

Subjective outcome evaluation of a gifted education program: the Project GIFT in Hong Kong.

BMC psychology·2026
Same author

[Haploidentical hematopoietic stem cell transplantation for advanced myelodysplastic syndrome patients with recurrent genetic abnormalities].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026
Same author

Utilisation trends and early outcomes of robotic arm-assisted total hip arthroplasty in a tertiary joint replacement centre in Hong Kong.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same author

[Screening and identification of vascular calcification-associated genes: implication of thymidine kinase 1].

Zhonghua xin xue guan bing za zhi·2025

Related Experiment Video

Updated: May 4, 2026

Reverse Total Shoulder Arthroplasty
10:10

Reverse Total Shoulder Arthroplasty

Published on: July 5, 2011

43.4K

Review article: Venous thromboembolism after total joint replacement.

K H Leung1, K Y Chiu, C H Yan

  • 1Department of Orthopaedics and Traumatology, Queen Mary Hospital, Hong Kong.

Journal of Orthopaedic Surgery (Hong Kong)
|December 25, 2013
PubMed
Summary

Venous thromboembolism (VTE) affects up to 84% of patients after joint replacement surgery. Effective prevention strategies combine mechanical and pharmacologic methods to reduce risks like pulmonary embolism.

Keywords:
arthroplasty, replacement, kneearthroplasty, replacement, hippostthrombotic syndromepulmonary embolismvenous thromboembolism

More Related Videos

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

18.5K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.1K

Related Experiment Videos

Last Updated: May 4, 2026

Reverse Total Shoulder Arthroplasty
10:10

Reverse Total Shoulder Arthroplasty

Published on: July 5, 2011

43.4K
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

18.5K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.1K

Area of Science:

  • Orthopedic Surgery
  • Vascular Medicine
  • Pharmacology

Background:

  • Venous thromboembolism (VTE) is a significant complication following total joint replacement (TJR), occurring in up to 84% of cases.
  • VTE can lead to severe outcomes including chronic post-thrombotic syndrome and potentially fatal pulmonary embolism.
  • Effective VTE prevention is crucial for successful surgical outcomes and patient recovery.

Purpose of the Study:

  • To review current strategies for VTE prophylaxis after TJR.
  • To emphasize the importance of combined mechanical and pharmacologic prevention.
  • To highlight advancements in thromboprophylactic agents targeting the coagulation pathway.

Main Methods:

  • Literature review of studies on VTE prophylaxis after TJR.
  • Analysis of the efficacy and safety of various mechanical and pharmacologic agents.
  • Discussion of novel agents targeting specific coagulation factors.

Main Results:

  • Combined mechanical and pharmacologic prophylaxis is superior to monotherapy.
  • Newer thromboprophylactic agents offer targeted approaches to anticoagulation.
  • Risk stratification and individualized prophylaxis are key to minimizing VTE events.

Conclusions:

  • A multimodal approach combining mechanical and pharmacologic interventions is essential for VTE prevention post-TJR.
  • Advances in anticoagulant therapies provide more targeted and effective prophylaxis options.
  • Optimizing VTE prevention strategies improves patient safety and surgical success rates.